Somewhat surprisingly, EMA reversed its negative decision on Lecanemab to treat Alzheimer's disease. However, I still think it is unlikely that the product will reach Swedish patients anytime soon.
Share this post
EMA's turnaround on Lecanemab
Share this post
Somewhat surprisingly, EMA reversed its negative decision on Lecanemab to treat Alzheimer's disease. However, I still think it is unlikely that the product will reach Swedish patients anytime soon.